Drug Development Pipeline

Explore our active programs

BRAIN-DRUG DELIVERY TECHNOLOGY

Psycheceutical has designed a product we believe will improve the quality of life for those suffering from Post-Traumatic Stress Disorder (PTSD) and Chronic Regional Pain Syndrome (CRPS) that is currently in human studies.

PTSD KEY STATS

13

Americans suffer from PTSD

6

of U.S. adults will have PTSD in their lifetime

13

of U.S. veterans will have PTSD in their lifetime

232

The estimated annual economic cost of PTSD

Drug Development Pipeline

Explore our active programs

BRAIN-DRUG DELIVERY TECHNOLOGY

PTSD KEY STATS

13

6

13

232

CRPS KEY STATS

200,000+

U.S. patients affected by CRPS annually

IMPAIRS

normal functions, sleep, and the activities of daily living

WORSENS

depression, anxiety and quality of life

Meet Our

Leadership Team

OUR TEAM

Psycheceutical Bioscience, Inc. is developing cutting-edge technologies to advance the safe and effective delivery of psychedelic pharmaceutical medicines.